Literature DB >> 10367848

Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies.

J E Fowler1, S A Bigler, N K Kilambi, S A Land.   

Abstract

OBJECTIVES: To determine whether the higher age-adjusted serum prostate-specific antigen (PSA) levels in black compared with white men with no clinical evidence of prostate cancer reflect racial differences in relationships between PSA and prostate volume.
METHODS: The age, PSA, findings on digital rectal examination (DRE), prostate volume, and PSA density were assessed prospectively in 810 consecutive, evaluable men who underwent prostate biopsy for suspected cancer but who had benign histologic findings.
RESULTS: Among the black and white patients, there were significant differences in age (mean 67.2 +/- 8.1 and 65.9 +/- 7.7 years, respectively, P = 0.02), PSA (median 4.7 and 3.9 ng/mL, respectively, P <0.0001), prostate volume (median 41 and 36 mL, respectively, P = 0.004), and PSA density (median 0.11 and 0.08 ng/mL/mL, respectively, P = 0.005). Multiple linear regression analyses showed that black race was significantly associated with increased prostate volume when controlled for age (P = 0.02), with increased PSA when controlled for prostate volume and age (P = 0.002), and with increased PSA density when controlled for age (P = 0.007). When controlled for prostate volume, PSA was not significantly different in black and white men 50 to 59 years old but was significantly greater in black men 60 to 69 and 70 to 79 years old (P = 0.02 and 0.002, respectively).
CONCLUSIONS: On a volume/volume basis, the benign prostatic tissue of black men appears to contribute more PSA to the circulating blood than does the benign prostatic tissue of white men, and the difference increases with advancing age. These phenomena provide a reasonable explanation for the age-adjusted racial differences in the PSA of men with no clinical evidence of cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367848     DOI: 10.1016/s0090-4295(99)00006-0

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancer.

Authors:  B A Rybicki; O N Kryvenko; Y Wang; M Jankowski; S Trudeau; D A Chitale; N S Gupta; A Rundle; D Tang
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-12-01       Impact factor: 5.554

2.  Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men.

Authors:  Jay H Fowke; Heather Munro; Lisa B Signorello; William J Blot; David F Penson
Journal:  J Gen Intern Med       Date:  2011-07-01       Impact factor: 5.128

3.  Potential effect of anti-inflammatory drug use on PSA kinetics and subsequent prostate cancer diagnosis: Risk stratification in black and white men with benign prostate biopsy.

Authors:  Oleksandr N Kryvenko; Yun Wang; Sudha Sadasivan; Nilesh S Gupta; Craig Rogers; Kevin Bobbitt; Dhananjay A Chitale; Andrew Rundle; Deliang Tang; Benjamin A Rybicki
Journal:  Prostate       Date:  2019-05-02       Impact factor: 4.104

4.  Prostate cancer: epidemiology and screening.

Authors:  M K Brawer; E D Crawford; J Fowler; M S Lucia; F H Schröeder
Journal:  Rev Urol       Date:  2000

5.  Dichotomous estimation of prostate volume: a diagnostic study of the accuracy of the digital rectal examination.

Authors:  Michael Z Su; Daniel Lenaghan; Henry H Woo
Journal:  World J Mens Health       Date:  2013-12-24       Impact factor: 5.400

Review 6.  Epidemiology of clinical benign prostatic hyperplasia.

Authors:  Kok Bin Lim
Journal:  Asian J Urol       Date:  2017-06-09

7.  Establishment of Reference Ranges for Prostate Volume and Annual Prostate Volume Change Rate in Korean Adult Men: Analyses of a Nationwide Screening Population.

Authors:  Jinsung Park; Dong-Gi Lee; Beomseok Suh; Sung Yong Cho; In Ho Chang; Sung Hyun Paick; Hyung-Lae Lee
Journal:  J Korean Med Sci       Date:  2015-07-15       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.